Researchers review the role of intratumoral microbiota in cancer development, suggesting its potential in predicting and treating various cancers.
J&J sues Samsung Bioepis over ‘surreptitious’ breach of Stelara biosimilar contract – Pharmaceutical Technology
J&J has reached several deals with pharma companies permitting biosimilar commercialisation after Stelara’s patent expired in July 2024. Image credit: Shutterstock/ Michael Vi. Johnson &